Form 8-K - Current report:
SEC Accession No. 0000950170-24-071345
Filing Date
2024-06-10
Accepted
2024-06-10 16:30:11
Documents
11
Period of Report
2024-06-05
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K beam-20240605.htm   iXBRL 8-K 62493
  Complete submission text file 0000950170-24-071345.txt   172413

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT beam-20240605.xsd EX-101.SCH 23857
14 EXTRACTED XBRL INSTANCE DOCUMENT beam-20240605_htm.xml XML 4518
Mailing Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 857-327-8775
Beam Therapeutics Inc. (Filer) CIK: 0001745999 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39208 | Film No.: 241033163
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)